
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#04ATA1695_3">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>
<!-- TOC_END -->
<P ALIGN="RIGHT"><FONT SIZE=2><A
NAME="kh1695_exhibit_1.2"> </A>
<A NAME="toc_kh1695_1"> </A>
<BR></FONT><FONT SIZE=2><B>Exhibit 1.2    <BR>    </B></FONT></P>

<P><FONT SIZE=2><B>THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR UNDER ANY STATE SECURITIES LAWS (THE "ACTS") AND MAY NOT BE SOLD OR OTHERWISE TRANSFERRED EXCEPT IN
ACCORDANCE WITH THE TERMS OF THIS NOTE AND THE ACTS.  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B> <A NAME="kh1695_secured_promissory_note"> </A>
<A NAME="toc_kh1695_2"> </A>
<BR>    SECURED PROMISSORY NOTE    <BR>    </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TD WIDTH="49%"><FONT SIZE=2>December&nbsp;17, 2004<BR>
Atlanta, Georgia</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%" ALIGN="RIGHT"><FONT SIZE=2>U.S. $7,800,000.00</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;FOR
VALUE RECEIVED, the undersigned Life Therapeutics Limited, a corporation organized under the laws of the Commonwealth of Australia (the
"</FONT><FONT SIZE=2><I>Parent</I></FONT><FONT SIZE=2>"); Life Gels,&nbsp;Inc. (f/k/a Gradipore,&nbsp;Inc.), a Delaware corporation ("</FONT><FONT SIZE=2><I>LG</I></FONT><FONT SIZE=2>"); Life
Therapeutics Plasma Holdings,&nbsp;Inc. (f/k/a Gradipore Plasma Holdings,&nbsp;Inc.), a Delaware corporation ("</FONT><FONT SIZE=2><I>LTPH</I></FONT><FONT SIZE=2>"); LifeSera,&nbsp;Inc., (f/k/a
Serologicals Specialty Biologics,&nbsp;Inc.), a Delaware corporation ("</FONT><FONT SIZE=2><I>LifeSera</I></FONT><FONT SIZE=2>"); LifeSera Nevada,&nbsp;Inc. (f/k/a Serologicals
Nevada,&nbsp;Inc.), a Nevada corporation ("</FONT><FONT SIZE=2><I>Nevada</I></FONT><FONT SIZE=2>"); LifeSera Business Trust (f/k/a Serologicals Business Trust), a Nevada business trust
("</FONT><FONT SIZE=2><I>LBT</I></FONT><FONT SIZE=2>"); LifeSera Investments, LLC (f/k/a Serologicals Investments, LLC), a Georgia limited liability company
("</FONT><FONT SIZE=2><I>LLC</I></FONT><FONT SIZE=2>"); LifeSera Management Partnership, LP (f/k/a Serologicals Management Partnership, LP), a Delaware limited partnership
("</FONT><FONT SIZE=2><I>LP</I></FONT><FONT SIZE=2>"); and Allegheny Biologicals,&nbsp;Inc., a Pennsylvania corporation ("</FONT><FONT SIZE=2><I>Allegheny</I></FONT><FONT SIZE=2>", and together
with LG, LTPH, LifeSera, Nevada, LBT, LLC, and LP, each a "</FONT><FONT SIZE=2><I>Company</I></FONT><FONT SIZE=2>" and collectively, the "</FONT><FONT SIZE=2><I>Companies</I></FONT><FONT SIZE=2>")
(the Parent and the Companies are hereinafter referred to collectively as the "</FONT><FONT SIZE=2><I>Makers</I></FONT><FONT SIZE=2>") hereby, jointly and severally,
promise to pay to the order of Serologicals Finance Company, a Delaware corporation (together with any subsequent holder of this Note, the "</FONT><FONT SIZE=2><I>Holder</I></FONT><FONT SIZE=2>"), at
its main office at 5655 Spalding Drive, Norcross, Georgia 30092, or at such other address as the Holder may from time to time designate in writing, the principal sum of Seven Million Eight Hundred
Thousand Dollars (U.S. $7,800,000.00), together with interest thereon, as calculated in accordance with the provisions of this Note. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Note is issued pursuant to that certain Exchange Agreement, dated as of the date hereof (the "</FONT><FONT SIZE=2><I>Exchange Agreement</I></FONT><FONT SIZE=2>"), between the
Parent and the Holder and shall be secured as more fully set forth in that certain Amended and Restated Security Agreement, dated as of the date hereof, made by the Companies in favor of the Holder.
Pursuant to the Exchange Agreement, the Holder has agreed to cancel certain promissory notes previously issued to Holder by the Companies in exchange for this Note and other consideration as set forth
in the Exchange Agreement. Capitalized terms used but not otherwise defined herein shall have the meanings set forth in the Exchange Agreement. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Payment of Principal.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Payment Schedule</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;The Makers shall pay to Holder the outstanding principal amount of this Note in accordance
with the following payment schedule, (each such payment of principal being referred to herein as a "</FONT><FONT SIZE=2><I>Payment Amount</I></FONT><FONT SIZE=2>") together with all accrued and
unpaid interest thereon (as set forth in Section&nbsp;2 below): </FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE WIDTH="65%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH WIDTH="25%" ALIGN="CENTER"><FONT SIZE=1><B>Payment Date</B></FONT><HR NOSHADE></TH>
<TH WIDTH="3%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="72%" ALIGN="CENTER"><FONT SIZE=1><B>Payment Amount</B></FONT><HR NOSHADE></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="25%" ALIGN="CENTER"><FONT SIZE=2>January 3, 2005</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="72%" ALIGN="CENTER"><FONT SIZE=2>$500,000</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="25%" ALIGN="CENTER"><FONT SIZE=2>June 30, 2005</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="72%" ALIGN="CENTER"><FONT SIZE=2>$500,000</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD WIDTH="25%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=2>September 30, 2005</FONT></TD>
<TD WIDTH="3%" VALIGN="TOP"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="72%" ALIGN="CENTER" VALIGN="TOP"><FONT SIZE=2>$1,000,000</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="25%" ALIGN="CENTER"><FONT SIZE=2>January 2, 2006</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="72%" ALIGN="CENTER"><FONT SIZE=2>$2,000,000</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="25%" ALIGN="CENTER"><FONT SIZE=2>June 30, 2006</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="72%" ALIGN="CENTER"><FONT SIZE=2>$850,000</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="25%" ALIGN="CENTER"><FONT SIZE=2>January 1, 2007</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="72%" ALIGN="CENTER"><FONT SIZE=2>$850,000</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="25%" ALIGN="CENTER"><FONT SIZE=2>July 2, 2007</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="72%" ALIGN="CENTER"><FONT SIZE=2>$850,000</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="25%" ALIGN="CENTER"><FONT SIZE=2>December&nbsp;31,&nbsp;2007</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="72%" ALIGN="CENTER"><FONT SIZE=2>All principal amounts outstanding together with all accrued but unpaid interest and fees and all other amounts payable pursuant to this Note</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="3",CHK=278124,FOLIO='blank',FILE='DISK013:[04ATA5.04ATA1695]KH1695A.;4',USER='SSTANSE',CD='23-DEC-2004;10:44' -->
<A NAME="page_kh1695_1_2"> </A>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Form of Payment</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Each Payment Amount (and accompanying fees, if any) shall be payable, at the Makers'
option: </FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(i)</FONT></DT><DD><FONT SIZE=2>in
lawful money of the United States which shall be legal tender for public and private debts at the time of payment (a "</FONT><FONT SIZE=2><I>Cash
Payment</I></FONT><FONT SIZE=2>"); or
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(ii)</FONT></DT><DD><FONT SIZE=2>subject
to clause&nbsp;1(c) below, in accordance with the formula and procedure set forth in clauses 1(d) and 1(e) below, by the issue of ordinary shares credited as
fully paid (the "</FONT><FONT SIZE=2><I>Shares</I></FONT><FONT SIZE=2>") of the Parent and ranking equally with and carrying all rights attaching to the existing issued ordinary shares of the Parent
at the time of their issue (a "</FONT><FONT SIZE=2><I>Share Payment</I></FONT><FONT SIZE=2>") equal to such Payment Amount; </FONT></DD></DL>
</UL>

<P><FONT SIZE=2>provided,
however, that the Makers agree that the first Payment Amount, due January&nbsp;3, 2005, shall be a Cash Payment. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Share Payment</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;The right of the Makers to elect to pay a Payment Amount by way of a Share Payment is
conditional on the following: </FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(i)</FONT></DT><DD><FONT SIZE=2>the
Makers have provided to the Holder a written notice (the "</FONT><FONT SIZE=2><I>Share Payment Notice</I></FONT><FONT SIZE=2>") at least ten (10)&nbsp;days prior
to the date on which the relevant Payment Amount is due indicating the Makers' intention to make a Share Payment in respect of that Payment Amount;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(ii)</FONT></DT><DD><FONT SIZE=2>the
holders of ordinary shares of the Parent approving the issue of the relevant Shares to the Holder for the purposes, and in accordance with the requirements, of the
official listing rules of the Australian Stock Exchange Limited ABN 98 008 624 691 ("</FONT><FONT SIZE=2><I>ASX</I></FONT><FONT SIZE=2>") ("</FONT><FONT SIZE=2><I>ASX Listing
Rules</I></FONT><FONT SIZE=2>") (including without limitation ASX Listing Rule&nbsp;7.1), provided that the Holder may waive this condition if the Parent provides the Holder with a Legal Opinion
that no such approval is required in relation to the issue of the relevant Shares under the ASX Listing Rules);
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(iii)</FONT></DT><DD><FONT SIZE=2>the
issue of the relevant Shares to the Holder is approved by a resolution passed at a general meeting of the Parent for the purposes, and in accordance with the
requirements, of item 7 of section&nbsp;611 of the Corporations Act 2001 (Commonwealth of Australia) ("</FONT><FONT SIZE=2><I>Corporations Act</I></FONT><FONT SIZE=2>") provided that the Holder may
waive this condition if the Parent provides the Holder with a Legal Opinion that the issue of the relevant Shares to the Holder without such approval will not contravene the Corporations Act;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(iv)</FONT></DT><DD><FONT SIZE=2>the
Parent confirms in writing to the Holder that the Parent will, immediately after the issue of the relevant Shares to the Holder, give ASX a notice under
section&nbsp;708A(6) of the Corporations Act and there is no excluded information that the Parent will be required to set out in that notice under sections 708A(7) and (8)&nbsp;of the Corporations
Act, provided that the Holder may waive this condition if the Parent provides the Holder with a Legal Opinion that an offer of the relevant Shares for sale within 12&nbsp;months after their issue
will not require disclosure under section&nbsp;707(3) of the Corporations Act;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(v)</FONT></DT><DD><FONT SIZE=2>the
Parent confirms in writing to the Holder that the Parent:
<BR><BR></FONT>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(A)</FONT></DT><DD><FONT SIZE=2>will,
immediately after the issue of the relevant Shares to the Holder, apply to ASX for quotation of the relevant Shares on ASX; and
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(B)</FONT></DT><DD><FONT SIZE=2>agrees
do all things required in order to secure such quotation;
<BR><BR></FONT></DD></DL>
</DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(v)</FONT></DT><DD><FONT SIZE=2>either:
<BR><BR></FONT>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(A)</FONT></DT><DD><FONT SIZE=2>the
Parent obtains all relevant approvals as may be required under the Foreign Acquisitions and Takeovers Act 1975 (Commonwealth of Australia)
("</FONT><FONT SIZE=2><I>FATA</I></FONT><FONT SIZE=2>") in respect </FONT></DD></DL>
</DD></DL>
</UL>
<P ALIGN="CENTER"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=2,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="3",CHK=1043753,FOLIO='2',FILE='DISK013:[04ATA5.04ATA1695]KH1695A.;4',USER='SSTANSE',CD='23-DEC-2004;10:44' -->
<A NAME="page_kh1695_1_3"> </A>
<UL>
<UL>
<UL>

<P><FONT SIZE=2>of
the issue of the relevant Shares (such approvals to be unconditional or subject to conditions that the Holder considers in its absolute discretion to be acceptable); or </FONT></P>

</UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(B)</FONT></DT><DD><FONT SIZE=2>the
expiry of the relevant period following the giving of notice in relation to the issue of the relevant Shares under FATA without any prohibition order being made
under FATA,
<BR><BR></FONT></DD></DL>
</UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><BR></DT><DD><FONT SIZE=2>provided
that the Holder may waive this condition if the Parent provides the Holder with a Legal Opinion that approval under FATA is not
required;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(vi)</FONT></DT><DD><FONT SIZE=2>the
Parent providing to the Holder immediately before the issue of the relevant Shares a Legal Opinion stating that:
<BR><BR></FONT>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(A)</FONT></DT><DD><FONT SIZE=2>upon
issuance to the Holder, the relevant Shares will be duly authorised, validly issued, fully paid and non-assessable and free from pre-emptive
rights;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(B)</FONT></DT><DD><FONT SIZE=2>the
Parent has obtained (or subject to satisfaction of the conditions in clauses 1(c)(ii)&nbsp;and (iii)&nbsp;above, will have obtained) all required approvals from
its board of directors, it shareholders and ASX in connection with the issue of the relevant Shares;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(C)</FONT></DT><DD><FONT SIZE=2>on
issue and following quotation of the relevant Shares on ASX, the Shares may be sold on ASX without any restriction;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(D)</FONT></DT><DD><FONT SIZE=2>the
issue of the relevant Shares will not violate any law, regulation or rule applicable to the Parent or the Parent's constitution or the terms of any material contract
or agreement to which the Parent is bound or to which it is subject,
<BR><BR></FONT></DD></DL>
</DD><DT style='margin-bottom:-11pt;'><BR></DT><DD><FONT SIZE=2>provided
that the Holder may in its absolute discretion waive this condition in whole or in part. </FONT></DD></DL>
</UL>

<P><FONT SIZE=2>In
this clause "</FONT><FONT SIZE=2><I>Legal Opinion</I></FONT><FONT SIZE=2>" means a written legal opinion by a firm of corporate lawyers in the Commonwealth of Australia approved by the Holder
(such approval not to be unreasonably withheld) and in a form and substance reasonably satisfactory to the Holder. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Issue of Shares to the Parent</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;If the Makers elect to pay a Payment Amount by a Share Payment, the relevant
Shares must be issued as directed by the Holder (including to the Holder's nominee). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Calculation of Share Amount</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;If the Makers elect to make a Share Payment in accordance with the provisions
set forth in Section&nbsp;1(b) above, the number of Shares to be issued pursuant to the Share Payment will be calculated by dividing: (i)&nbsp;the Payment Amount (converted into Australian Dollars
at the "Exchange Rate" (as defined below)) owed to the Holder for the payment period by (ii)&nbsp;the 20-Day Moving Average (as defined below) of the Shares. The 20-Day
Moving Average shall be the arithmetic average of the closing price of the Shares on ASX during the twenty trading days ending three trading days prior to the applicable Share Payment Notice. The term
"</FONT><FONT SIZE=2><I>Exchange Rate</I></FONT><FONT SIZE=2>" means the mid-range rate for trading among banks in amounts of U.S. $1&nbsp;million and more published in </FONT> <FONT SIZE=2><I>The Wall Street Journal</I></FONT><FONT SIZE=2> on the
day prior to the date of the applicable Share Payment Notice. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Interest Payments.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Accrual</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Interest shall accrue on the outstanding principal balance in an amount equal to the
Short-Term Applicable Federal Rate from time to time in effect during the period for which interest is computed, compounded annually. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Payment of Interest</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;All then accrued and unpaid interest shall become due on each of the payment dates set
forth in Section&nbsp;1(a) (each, an "</FONT><FONT SIZE=2><I>Interest Payment</I></FONT><FONT SIZE=2>") and shall be paid to the Holder concurrently. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=3,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="3",CHK=240391,FOLIO='3',FILE='DISK013:[04ATA5.04ATA1695]KH1695A.;4',USER='SSTANSE',CD='23-DEC-2004;10:44' -->
<A NAME="page_kh1695_1_4"> </A>
<BR>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Form of Interest Payment</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Each Interest Payment shall be payable, at the Makers' option: </FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(i)</FONT></DT><DD><FONT SIZE=2>In
lawful money of the United States which shall be legal tender for public and private debts at the time of payment (an "</FONT><FONT SIZE=2><I>Interest Cash
Payment</I></FONT><FONT SIZE=2>"); or
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(ii)</FONT></DT><DD><FONT SIZE=2>Subject
to the terms of clause&nbsp;(d) below, by the prompt sale, transfer and assignment to Holder of blood serum or diagnostic inventory (the
"</FONT><FONT SIZE=2><I>Interest Inventory</I></FONT><FONT SIZE=2>") owned by Makers. The established value of the Interest Inventory shall be computed in accordance with the then established book
value of said Interest Inventory; </FONT><FONT SIZE=2><I>provided, however,</I></FONT><FONT SIZE=2> if the Interest Inventory to be transferred to Holder was originally acquired by Maker from the
sale of all of the issued and outstanding shares of LifeSera,&nbsp;Inc. (f/k/a Serologicals Specialty Biologics,&nbsp;Inc.) by Holder, pursuant to the Stock Purchase Agreement dated
January&nbsp;15, 2004 (the "</FONT><FONT SIZE=2><I>Acquisition</I></FONT><FONT SIZE=2>"), then in such cases the established value of the Interest Inventory shall be computed in accordance with the
book value of said Interest Inventory established at the time of the Acquisition. </FONT></DD></DL>
</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Delivery of Interest Inventory</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;In the event that an Interest Payment is made by the sale, transfer and
assignment of Interest Inventory, in each case Makers agree, at the Holders' election, to deliver the Interest Inventory to such location as may be specified by the Holders, or to hold and maintain
the Interest Inventory at a mutually acceptable location owned by one or more Maker, in which case Holders shall pay all reasonable costs and expenses associated with the holding and maintenance of
the Interest Inventory. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Prepayment of Principal Amount.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Makers may, on any due date of a principal payment as set forth in
Section&nbsp;1(a) above (a "</FONT><FONT SIZE=2><I>Payment Date</I></FONT><FONT SIZE=2>"), without premium or penalty, prepay all or any portion of the outstanding principal amount of this Note. In
connection with each prepayment of principal hereunder, the Makers shall also pay all accrued and unpaid interest related to the principal amount of this Note being so prepaid, in accordance with the
provisions of Section&nbsp;2 above. Any prepayment of outstanding principal hereunder shall be applied to the Payment Amounts in inverse order of maturity. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Events of Default.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Note, an "</FONT><FONT SIZE=2><I>Event of
Default</I></FONT><FONT SIZE=2>" shall be deemed to have occurred if: </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;the
Makers fail to pay when due and payable the full amount of any Payment Amount or Interest Payment; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;the
Makers fail to perform or observe any other provision, or breaches any representation, warranty or covenant, contained in this Note, the Security Agreement, the
Exchange Agreement, the Release or any of the other agreements contemplated thereby, and such failure or breach is not cured within thirty (30)&nbsp;days after such written notice of the occurrence
thereof; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;any
Maker makes an assignment for the benefit of creditors or admits in writing its inability to pay its debts generally as they become due; or an order, judgment or
decree is entered adjudicating any Maker bankrupt or insolvent; or any order for relief with respect to any Maker is entered under applicable laws or rules governing bankruptcy; or any Maker petitions
or applies to any tribunal for the appointment of a custodian, trustee, receiver or liquidator of a Maker, or of any substantial part of any Maker, or commences any proceeding relating to any Maker
under any bankruptcy, reorganization, arrangement, insolvency, readjustment of debt, dissolution or liquidation law of any jurisdiction; or any such petition or application is filed, or any such
proceeding is commenced, against any Maker and either (A)&nbsp;the Maker by any act indicates its approval thereof, consent thereto or acquiescence therein, or (B)&nbsp;such petition, application
or proceeding is not dismissed within sixty (60)&nbsp;days; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;any
Maker defaults in the performance of any obligation or agreement related to Indebtedness (as defined below) if the effect of such default is to cause an amount
exceeding $250,000 to become due prior to its stated maturity or to permit (or, with the giving of notice or lapse of time or </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=4,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="3",CHK=664404,FOLIO='4',FILE='DISK013:[04ATA5.04ATA1695]KH1695A.;4',USER='SSTANSE',CD='23-DEC-2004;10:44' -->
<A NAME="page_kh1695_1_5"> </A>
<BR>

<P><FONT SIZE=2>both,
would permit) the holder or holders of any obligations to cause an amount exceeding $250,000 to become due prior to its stated maturity; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;the
transfer of capital stock or other equity interest of the Companies by Life Sera or any Affiliate, through assignment, sale, dividend or otherwise; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;the
Makers' ordinary shares shall cease to be traded on the Australian Stock Exchange; or </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;&nbsp;any
ordinary shares of capital stock issued to Holder pursuant to a Share Payment shall become restricted or shall no longer be freely tradeable on the Australian Stock
Exchange. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Consequences of Events of Default.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;If
an Event of Default of the type described in Sections 3(a), (b), (d)&nbsp;or (e), has occurred, the Holder may declare all or any portion of the outstanding
principal amount of this Note (together with any accrued interest thereon and all fees, charges and other amounts due and payable with respect thereto) to be immediately due and payable and may demand
immediate payment of all or any portion of the outstanding principal amount of this Note (together with all such other amounts then due and payable) owned by the Holder without further demand,
presentment, protest or notice of any kind. If the Holder demands immediate payment of all or any portion of this Note, the Makers shall promptly pay to the Holder all such amounts due and payable;
provided, however, that the Makers shall have a ten (10)&nbsp;day period in the event that the Parent chooses to make a Share Payment in accordance with Section&nbsp;1(b), (c)&nbsp;and (d). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;If
an Event of Default of the type described in Section&nbsp;3(c), (f)&nbsp;or (g)&nbsp;has occurred, the aggregate principal amount of this Note (together with
all accrued interest thereon and all other amounts due and payable with respect thereto) shall become immediately due and payable without any action on the part of the Holder, and the Makers shall
immediately pay to the Holder all amounts due and payable with respect to this Note. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;The
Holder shall also have any other rights which it may have been afforded under any contract or agreement at any time and any other rights which such holder may have
pursuant to applicable law, including, without limitation, any and all rights it may have pursuant to the Security Agreement. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Default Rate.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Upon any failure to make any payment hereunder when due, the Makers, jointly and severally,
agree to pay interest to Holder at a rate per annum equal to One Month LIBOR plus five hundred basis points on the aggregate indebtedness represented hereby, including accrued interest, until such
aggregate indebtedness is paid in full. The Makers shall also pay to Holder, in addition to the amount due, all costs of collecting, securing or attempting to collect or secure this Note, including,
without limitation, court costs and attorneys' fees, including attorneys' fees on any appeal by either the Makers or Holder. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Waivers.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;With respect to the amounts due pursuant to this Note, the Makers waive the following:
(a)&nbsp;all rights of exemption of property from levy or sale under execution or other process for the collection of debts under any applicable laws; (b)&nbsp;demand, presentment, protest, notice
of dishonor, notice of nonpayment, suit against any party, diligence in collection, and all other requirements necessary to enforce this Note; and (c)&nbsp;any further receipt by, or acknowledgment
of, any collateral now or hereafter deposited as security for the obligations hereunder. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Transfer</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;The Holder may sell, transfer or assign this Note or any interest in this without the prior written
consent of the Company; </FONT><FONT SIZE=2><I>provided</I></FONT><FONT SIZE=2>, </FONT><FONT SIZE=2><I>however</I></FONT><FONT SIZE=2>, that Holder acknowledges that this Note has not been
registered under the Securities Act of 1933 (the "</FONT><FONT SIZE=2><I>Act</I></FONT><FONT SIZE=2>"), as amended, or any state securities laws, and that the Note may not be sold, transferred or
otherwise disposed except (i)&nbsp;pursuant to a valid registration statement effective under the Act and applicable state securities laws or (ii), pursuant to and after delivery to the Makers of an
opinion of counsel, reasonably satisfactory to the Company, </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=5,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="3",CHK=701217,FOLIO='5',FILE='DISK013:[04ATA5.04ATA1695]KH1695A.;4',USER='SSTANSE',CD='23-DEC-2004;10:44' -->
<A NAME="page_kh1695_1_6"> </A>
<BR>

<P><FONT SIZE=2>that
the sale, transfer or assignment complies with an available exemption from the registration requirements of the Act. Notwithstanding the foregoing, the Holder shall be permitted to pledge this
Note to JPMorgan Chase Bank, as Administrative Agent (the "Agent"), pursuant to that certain Credit Agreement, dated as of October&nbsp;14, 2004, among Serologicals Corporation, the lenders named
therein and the Agent, to secure the indebtedness from time-to-time outstanding thereunder, without providing a legal opinion of the type contemplated by clause&nbsp;(ii) of
the preceding sentence. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Amendment</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;This Note may not be amended, altered or modified except by an instrument executed by the Holder
and the Company. No course of dealing between or among any Persons (as defined below) having any interest in this Note shall be deemed effective to modify, amend or discharge any part of this Note or
any rights or obligations of any Person under or by reason of this Note. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;No Waiver</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Failure on the part of the Holder to insist on the strict performance of any or all of the terms,
provisions, and covenants contained in this Note shall not be construed as a waiver or relinquishment for the future of any term, provision or covenant herein. The Holder shall not by any act, delay,
omission, or otherwise be deemed to have waived any of its rights or remedies, and no waiver of any kind shall be valid unless in writing and signed by Holder. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Application of Payments</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;All payments shall be applied first to interest then due and payable, if any, and
any balance shall be applied in reduction of principal in accordance with the terms of this Note. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Form of Payments</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;All payments, other than Share Payments, shall be payable in lawful money of the United
States of America which shall be legal tender for public and private debts at the time of payment. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Interest Rate</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Any interest payable hereunder shall accrue and be calculated on the basis of the actual
number of days in the related period over 365&nbsp;days. In no event shall the amount of interest due or payable hereunder exceed the maximum rate of interest allowed by applicable law, and in the
event such payment is inadvertently paid by the Makers or inadvertently received by Holder, then such excess sum shall be credited as a payment of principal, unless the Makers elect to have such
excess sum refunded to them forthwith. It is the express intent hereof that the Makers not pay and the Holder not
receive, directly or indirectly, interest in excess of that which may be legally paid by the Makers under applicable law. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Remedies Cumulative</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;All rights and remedies of the Holder under the terms of this Note and applicable
statutes or rules of law shall be cumulative, and may be exercised successively or concurrently. The Makers agree that there are no defenses, equities or setoffs with respect to the obligations set
forth herein. The obligations of the Makers hereunder shall be binding upon and enforceable against the Makers and their respective successors, heirs, executors and legal representatives. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Business Days</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;If any payment hereunder is due, or any time period for giving notice or taking action
expires, on a day which is a Saturday, Sunday or legal holiday in the State of Georgia or the Commonwealth of Australia, the payment shall be due and payable on, and the time period shall
automatically be extended to, the next business day immediately following such Saturday, Sunday or legal holiday, and interest, if applicable, shall continue to accrue at the required rate hereunder
until any such payment is made. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Severability</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Any provision of this Note which is prohibited or unenforceable in any jurisdiction shall, as
to such jurisdiction, be effective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any
jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=6,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="3",CHK=102064,FOLIO='6',FILE='DISK013:[04ATA5.04ATA1695]KH1695A.;4',USER='SSTANSE',CD='23-DEC-2004;10:44' -->
<A NAME="page_kh1695_1_7"> </A>
<BR>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Time of the Essence</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;TIME IS OF THE ESSENCE OF THIS NOTE. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18.</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Governing Law</I></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;The Note shall be governed as to the validity, interpretation, construction, effect, and in
all other respects, by the laws and decisions of the State of Delaware giving effect to its conflicts of laws principles. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>[SIGNATURE
PAGES FOLLOW] </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>7</FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=7,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="3",CHK=845408,FOLIO='7',FILE='DISK013:[04ATA5.04ATA1695]KH1695A.;4',USER='SSTANSE',CD='23-DEC-2004;10:44' -->
<A NAME="page_kh1695_1_8"> </A>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN
WITNESS WHEREOF, each of the undersigned has caused this instrument to be executed by its duly authorized President on the day and year first above written. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>LIFE THERAPEUTICS, LTD.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFE GELS,&nbsp;INC.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFE THERAPEUTICS PLASMA HOLDINGS,&nbsp;INC.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFESERA,&nbsp;INC.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFESERA NEVADA,&nbsp;INC.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFESERA BUSINESS TRUST</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFESERA INVESTMENTS, LLC</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
LIFESERA MANAGEMENT PARTNERSHIP, LP</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name: John Manusu<BR>
Title: Authorized Officer</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2><BR>
ALLEGHENY BIOLOGICALS,&nbsp;INC.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="5%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="50%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>JOHN MANUSU</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3><FONT SIZE=2>Name:<BR>
Title:</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER"><FONT SIZE=2>8</FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=8,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="3",CHK=655459,FOLIO='8',FILE='DISK013:[04ATA5.04ATA1695]KH1695A.;4',USER='SSTANSE',CD='23-DEC-2004;10:44' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="04ATA1695_3">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2><A HREF="#toc_kh1695_1">Exhibit 1.2</A></FONT><BR>
</UL>
<FONT SIZE=2><A HREF="#toc_kh1695_2">SECURED PROMISSORY NOTE</A></FONT><BR>
<!-- SEQ=,FILE='QUICKLINK',USER=SSTANSE,SEQ=,EFW="2149161",CP="SEROLOGICALS CORPORATION",DN="3" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>

